New Products

ENGLEWOOD CLIFFS, N.J. — Unilever is launching two new butter-like spreads, the company said.

The food, home and personal care supplier said it would debut I Can't Believe It's Not Butter! Deliciously Simple and Country Crock Simply Delicious at the Food Network New York City Wine & Food Festival, which is presented by Food & Wine magazine.

The spreads are made with such simple ingredients as canola oil, nonfat yogurt, salt and natural flavors, with no artificial preserves or trans fat.

DARMSTADT, Germany — The Food and Drug Administration has approved a pre-filled injector pen made by EMD Serono for infertile women, the company said Friday.

The drug maker — the U.S. subsidiary of Germany's Merck Serono, so-called to distinguish it from U.S.-based Merck & Co. — announced the approval of Gonal-f RFF Redi-ject (follitropin alfa), a disposable pre-filled injector pen intended for injection under the skin of a liquid formulation of Gonal-f RFF. The pens will be available in the United States in December.

CINCINNATI — Procter & Gamble’s Oral-B has unveiled what it says is its most innovative power brush to date — the Oral-B Black 7000.

NEW YORK — Nestle is planning to launch a cup version of its popular Butterfinger candy bar next year, the company said.

The candy maker said it would introduce the Butterfinger Peanut Butter Cups, calling it one of the company's biggest candy launches. In addition, for the first time it will feature one of its brands in a Super Bowl commercial.

MONTVALE, N.J. — Tetley USA, the U.S. subsidiary of the U.K.-based tea company, released results of a survey of tea drinkers to coincide with the launch of its new Black & Green blend.

CINCINNATI — Prasco Labs will distribute an authorized generic for reducing serum phosphate in patients with end-stage renal disease under a contract with Shire, Prasco said Thursday.

The company, which focuses on authorized generic drugs, announced the deal for lanthanum carbonate chewable tablets in the 500-mg, 750-mg and 1,000-mg strengths. The drug is a version of Shire's Fosrenol. Authorized generics are branded drugs marketed under their generic names at a discounted price, usually through a third-party company under contract with the branded drug's manufacturer.

BAGSVÆRD, Denmark — The Food and Drug Administration has approved a new drug made by Novo Nordisk for treating hemophilia A, the Danish drug maker said.

Novo Nordisk announced the approval of Novoeight (turoctocog alfa), a recombinant coagulation factor VIII, for adults and children with hemophilia, a disease caused by factor VIII deficiency that results in uncontrollable bleeding.

LAS VEGAS — Lansinoh Laboratories is expanding its product offering with six new items for mass outlets in 2014, which are being introduced this week at the ABC Kids Expo, the company announced Wednesday.  

The items are inspired by Lansinoh's new Pump-Store-Feed system, and are designed to make breastfeeding as convenient as possible. The new products include two breast pumps and a redesign of the Lansinoh mOmma bottle.